Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 18, 2022

SELL
$126.46 - $235.05 $186,022 - $345,758
-1,471 Closed
0 $0
Q4 2021

Jul 11, 2022

SELL
$225.82 - $368.51 $483,480 - $788,979
-2,141 Reduced 59.27%
1,471 $374,000
Q3 2021

Jul 11, 2022

BUY
$221.9 - $484.47 $479,747 - $1.05 Million
2,162 Added 149.1%
3,612 $1.39 Million
Q2 2021

Jul 11, 2022

BUY
$129.91 - $234.98 $188,369 - $340,721
1,450 New
1,450 $341,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Range Financial Group LLC Portfolio

Follow Range Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.